Available datapackage for study 'Daratumumab (HuMax®-CD38) Safety Study in Multiple Myeloma - Open Label, Dose-escalation Followed by Open Label, Single-arm Study'

Name: Available datapackage for study 'Daratumumab (HuMax®-CD38) Safety Study in Multiple Myeloma - Open Label, Dose-escalation Followed by Open Label, Single-arm Study'
Creator: Vivli
Published: 2025-06-01 01:02:39
License: 暂无描述

DataCite Commons2025-06-01 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/dataPackages/PR00004746.0

下载链接

链接失效反馈

官方服务：

资源简介：

Establishment of safety profile of HuMax-CD38 when given as monotherapy in participants with multiple myeloma relapsed from or refractory to at least 2 different cytoreductive therapies and without further established treatment options.

提供机构：

Vivli

创建时间：

2022-11-18